132 related articles for article (PubMed ID: 32098465)
21. Percutaneous cholecystostomy for the diagnosis and treatment of acute calculous and acalculous cholecystitis.
Lo LD; Vogelzang RL; Braun MA; Nemcek AA
J Vasc Interv Radiol; 1995; 6(4):629-34. PubMed ID: 7579876
[TBL] [Abstract][Full Text] [Related]
22. [Acute cholecystitis due to microscopic polyangiitis:a case report].
Kotsuka M; Tsukamoto T; Kanazawa A; Shimizu S; Nakajima Y; Kodai S; Komatsu S
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(12):2167-2174. PubMed ID: 29213028
[TBL] [Abstract][Full Text] [Related]
23. Acute cholecystitis immediately after radical gastrectomy: a report of three cases.
Liu XS; Zhang Q; Zhong J; Zhu KK; Mu YC; Yu JR
World J Gastroenterol; 2010 Jun; 16(21):2702-4. PubMed ID: 20518096
[TBL] [Abstract][Full Text] [Related]
24. UNCOMMON SIDE EFFECTS OF SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CANCER: CASE REPORT.
Šeparović R; Pavlović M; Silovski T; Silovski H; Tečić Vuger A
Acta Clin Croat; 2018 Sep; 57(3):577-580. PubMed ID: 31168192
[TBL] [Abstract][Full Text] [Related]
25. [Two cases of bowel perforation in patients with metastatic renal cancer treated with a molecularly targeted drug].
Kobayashi H; Ashikari A; Namitome R; Yagi Y; Kohno Y; Nishiyama T; Saito S
Nihon Hinyokika Gakkai Zasshi; 2012 Sep; 103(5):660-4. PubMed ID: 23342925
[TBL] [Abstract][Full Text] [Related]
26. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Motzer RJ; Rini BI; McDermott DF; Arén Frontera O; Hammers HJ; Carducci MA; Salman P; Escudier B; Beuselinck B; Amin A; Porta C; George S; Neiman V; Bracarda S; Tykodi SS; Barthélémy P; Leibowitz-Amit R; Plimack ER; Oosting SF; Redman B; Melichar B; Powles T; Nathan P; Oudard S; Pook D; Choueiri TK; Donskov F; Grimm MO; Gurney H; Heng DYC; Kollmannsberger CK; Harrison MR; Tomita Y; Duran I; Grünwald V; McHenry MB; Mekan S; Tannir NM;
Lancet Oncol; 2019 Oct; 20(10):1370-1385. PubMed ID: 31427204
[TBL] [Abstract][Full Text] [Related]
27. Long-term results of percutaneous cholecystostomy for definitive treatment of acute acalculous cholecystitis : a 10-year single-center experience.
Ozyer U
Acta Gastroenterol Belg; 2018; 81(3):393-397. PubMed ID: 30350527
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous cholecystostomy: A simple bridge to surgery or an alternative option for the management of acute cholecystitis?
Stanek A; Dohan A; Barkun J; Barkun A; Reinhold C; Valenti D; Cassinotto C; Gallix B
Am J Surg; 2018 Sep; 216(3):595-603. PubMed ID: 29429546
[TBL] [Abstract][Full Text] [Related]
29. Acute acalculous cholecystitis following COVID-19 vaccination: a case report.
Kyungu FM; Katumba AM; Kamwira HL; Mayikuli AV; Mala A; Banza MI; Manirou HM; Tosali FB; Mulenga PC
Pan Afr Med J; 2022; 41():291. PubMed ID: 35855047
[TBL] [Abstract][Full Text] [Related]
30. Can levocarnitine supplementation improve fatigue caused by sunitinib as a treatment for renal cell carcinoma? A single-center prospective pilot study.
Shindo T; Kobayashi K; Tanaka T; Masumori N
Support Care Cancer; 2019 Apr; 27(4):1491-1496. PubMed ID: 30374764
[TBL] [Abstract][Full Text] [Related]
31. Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial.
Zhou AP; Bai Y; Song Y; Luo H; Ren XB; Wang X; Shi B; Fu C; Cheng Y; Liu J; Qin S; Li J; Li H; Bai X; Ye D; Wang J; Ma J
Oncologist; 2019 Aug; 24(8):e702-e708. PubMed ID: 30902918
[TBL] [Abstract][Full Text] [Related]
32. Sunitinib-associated hyperammonemic encephalopathy successfully managed with higher intensity conventional hemodialysis: A case report.
Haroon S; Ko S; Wong A; Tan PS; Lee E; Lau T
Medicine (Baltimore); 2021 Feb; 100(5):e24313. PubMed ID: 33592876
[TBL] [Abstract][Full Text] [Related]
33. Endosonography-guided gallbladder drainage versus percutaneous cholecystostomy in very high-risk surgical patients with acute cholecystitis: an international randomised multicentre controlled superiority trial (DRAC 1).
Teoh AYB; Kitano M; Itoi T; Pérez-Miranda M; Ogura T; Chan SM; Serna-Higuera C; Omoto S; Torres-Yuste R; Tsuichiya T; Wong KT; Leung CH; Chiu PWY; Ng EKW; Lau JYW
Gut; 2020 Jun; 69(6):1085-1091. PubMed ID: 32165407
[TBL] [Abstract][Full Text] [Related]
34. [A case of pneumatosis intestinalis associated with sunitinib treatment for renal cell carcinoma].
Choi YA; Sim EH; Lee KE; Ko SY; Seo MJ; Yang YJ; Park JC; Park SY
Korean J Gastroenterol; 2013 Jun; 61(6):347-50. PubMed ID: 23877217
[TBL] [Abstract][Full Text] [Related]
35. [Acute acalculous gangrenous cholecystitis in postoperative period after orthopedic surgery: about a case].
Cheikhrouhou H; Jmal K; Kharrat A; Keskes M; Karoui A
Pan Afr Med J; 2017; 27():8. PubMed ID: 28748010
[TBL] [Abstract][Full Text] [Related]
36. [Imaging of a thickened-wall gallbladder].
Zins M; Boulay-Coletta I; Molinié V; Mercier-Pageyral B; Jullès MC; Rodallec M; Petit E; Berrod JL
J Radiol; 2006 Apr; 87(4 Pt 2):479-93. PubMed ID: 16691177
[TBL] [Abstract][Full Text] [Related]
37. Pre-surgical sunitinib treatment enabling nephron-sparing surgery in a patient with renal cell carcinoma in a solitary kidney.
Tochigi K; Funahashi Y; Mori A; Matsukawa Y; Kato M; Gotoh M
Nagoya J Med Sci; 2019 May; 81(2):337-340. PubMed ID: 31239602
[TBL] [Abstract][Full Text] [Related]
38. [Gas-Producing Splenic Abscess after Spleen Metastasis of Left Renal Cell Carcinoma Spleen Metastasis Successfully Treated with Sunitinib].
Kunishige R; Ozeki T; Hamaguchi M; Toyoda S; Hashimoto M; Kikuchi T; Nishimoto M; Shimizu N; Mori Y; Minami T; Nozawa M; Nose K; Yoshimura K; Uemura H
Hinyokika Kiyo; 2021 Feb; 67(2):63-66. PubMed ID: 33657773
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous cholecystostomy (PC) in the management of acute cholecystitis in high risk patients.
Saeed SA; Masroor I
J Coll Physicians Surg Pak; 2010 Sep; 20(9):612-5. PubMed ID: 20810055
[TBL] [Abstract][Full Text] [Related]
40. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Rini BI; Plimack ER; Stus V; Gafanov R; Hawkins R; Nosov D; Pouliot F; Alekseev B; Soulières D; Melichar B; Vynnychenko I; Kryzhanivska A; Bondarenko I; Azevedo SJ; Borchiellini D; Szczylik C; Markus M; McDermott RS; Bedke J; Tartas S; Chang YH; Tamada S; Shou Q; Perini RF; Chen M; Atkins MB; Powles T;
N Engl J Med; 2019 Mar; 380(12):1116-1127. PubMed ID: 30779529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
